tiprankstipranks
Trending News
More News >
ATS Corporation (ATS)
NYSE:ATS
US Market

ATS Corporation (ATS) Earnings Dates, Call Summary & Reports

Compare
52 Followers

Earnings Data

Report Date
May 14, 2026
Before Open (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
0.33
Last Year’s EPS
0.3
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2026
Earnings Call Date:Feb 04, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlights solid top-line growth, strong adjusted operating earnings expansion (+21.6% YoY), a healthy $2.1 billion backlog (Life Sciences and Energy strength), positive operating cash flow, and disciplined capital allocation plans under new leadership. Offsetting items include gross margin compression (111 bps), year-over-year bookings decline (–7%), ongoing Transportation weakness, elevated SG&A and restructuring costs (program increased to ~$20M), and working capital still above target. Management emphasized margin expansion via ABM, aftermarket growth and disciplined M&A, and embedded services to improve recurring margins. Overall, the positive operational momentum, robust backlog and profitability gains materially outweigh the mix-related margin pressure and short-term execution/timing headwinds.
Company Guidance
Management guided Q4 revenue of $710–$750 million and reiterated fiscal‑2026 CapEx & intangible spend of $70–$90 million (Q3 spend $16.6m), while increasing the announced restructuring to ~ $20 million (Q3 charge $5.5m) with some savings to be reinvested into growth in FY‑27; net debt/adjusted EBITDA was ~3.0x (target 2–3x), trailing‑12‑month book‑to‑bill 1.06:1, and non‑cash working capital improved to 16.4% of revenues (goal <15%). Key Q3 metrics cited: order bookings $821m (down 7% YoY, up ~12% sequentially), revenues $761m (up 16.7% YoY; 12.6% organic, +4.1% FX), order backlog ≈ $2.1bn (Life Sciences $1.1bn; Food & Beverage $203m; Energy $296m, +87% YoY; Consumer $321m), adjusted earnings from operations ~$80m (adjusted EPS $0.48), gross margin 29.6% (down 111 bps YoY), and operating cash flow $115m YTD with revenue growth YTD 13.6% (≈8% organic) and adjusted earnings from operations up 14% YTD.
Revenue Growth
Q3 revenues of $761 million, up 16.7% year-over-year (organic growth ~12.6% and ~4.1% benefit from FX). Year-to-date revenue growth of 13.6% (approx. 8% organic).
Strong Profitability Improvement
Adjusted earnings from operations of $79.9–$80.0 million in Q3, up 21.6% year-over-year; adjusted EPS of $0.48 for the quarter.
Robust Order Backlog and Book-to-Bill
Order backlog of approximately $2.1 billion at quarter end and a trailing 12-month book-to-bill ratio of 1.06:1, indicating continued demand coverage.
Order Bookings Momentum (Sequential)
Order bookings in Q3 of $821 million, up almost 12% sequentially and supported by activity across multiple end markets.
Life Sciences Strength
Life Sciences backlog of $1.1 billion and Life Sciences revenue of $391 million in Q3 (the second-highest in ATS history); continued momentum in radiopharma and GLP-1 auto-injector programs.
Energy Segment Acceleration
Energy order backlog reached a record $296 million in Q3, up 87% versus Q3 last year, driven by nuclear refurbishment and life-extension projects as well as participation in new-build reactor work including SMRs.
Consumer & Food & Beverage Backlog Highlights
Consumer Products backlog a record $321 million (driven by a large enterprise warehouse packaging program); Food & Beverage backlog $203 million with a strong funnel in core processing markets.
Cash Generation and Working Capital Progress
Operating cash flow of $115 million in Q3; non-cash working capital at 16.4% of revenues, an improvement sequentially and toward the stated target of less than 15%.
Capital Allocation & Balance Sheet Discipline
Q3 CapEx and intangibles of $16.6 million; fiscal '26 CapEx and intangible guidance narrowed/downward to $70–$90 million; net debt to adjusted EBITDA ~3x, signaling progress toward leverage target range of 2–3x and disciplined approach to M&A and reinvestment.
Strategic & Organizational Moves
New CEO appointed (Doug Wright) with focus on lean/ABM execution and margin expansion; key leadership additions (Sarah Moore for Life Sciences, Simon Roberts for Packaging & Food); services integrated into operating units to drive recurring, margin-enhancing aftermarket revenue.

ATS Corporation (ATS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ATS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 14, 2026
2026 (Q4)
0.33 / -
0.303
Feb 04, 2026
2026 (Q3)
0.32 / 0.35
0.23650.00% (+0.12)
Nov 05, 2025
2026 (Q2)
0.32 / 0.33
0.18580.00% (+0.15)
Aug 07, 2025
2026 (Q1)
0.32 / 0.30
0.369-18.00% (-0.07)
May 28, 2025
2025 (Q4)
0.28 / 0.30
0.48-36.92% (-0.18)
Feb 05, 2025
2025 (Q3)
0.26 / 0.24
0.48-50.77% (-0.24)
Nov 06, 2024
2025 (Q2)
0.25 / 0.18
0.465-60.32% (-0.28)
Aug 08, 2024
2025 (Q1)
0.39 / 0.37
0.51-27.54% (-0.14)
May 16, 2024
2024 (Q4)
0.42 / 0.48
0.539-10.96% (-0.06)
Feb 07, 2024
2024 (Q3)
0.47 / 0.48
0.38425.00% (+0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ATS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 04, 2026
$28.39$30.25+6.55%
Nov 05, 2025
$26.73$29.56+10.59%
Aug 07, 2025
$30.99$29.52-4.74%
May 28, 2025
$30.39$30.20-0.63%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does ATS Corporation (ATS) report earnings?
ATS Corporation (ATS) is schdueled to report earning on May 14, 2026, Before Open (Confirmed).
    What is ATS Corporation (ATS) earnings time?
    ATS Corporation (ATS) earnings time is at May 14, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ATS EPS forecast?
          ATS EPS forecast for the fiscal quarter 2026 (Q4) is 0.33.